Mariner’s CureVac CVAC Stock Holding History

Mariner’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,312	Closed	-$30.8K	–	3408
2024 Q3	$30.8K	Sell	10,312 -5,327	-34%	-$17.5K	﹤0.01%	3225
2024 Q2	$53.1K	Buy	15,639 +787	+5%	+$2.57K	﹤0.01%	3048
2024 Q1	$45K	Buy	+14,852	New	+$52.1K	﹤0.01%	3043

Other funds holding CVAC

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Mariner's CVAC Position: Q4 2024 in Review

Mariner sold out of CureVac (CVAC) in Q4 2024, closing a stake of 10,312 shares — an estimated $30.8K sold.

Mariner first reported a position in CVAC in Q1 2024 and held it in 3 quarters. The position peaked at $53.1K in Q2 2024. 75 funds tracked by Wall St. Rank hold CVAC as of Q4 2024.

Mariner reported no remaining CureVac position as of Q4 2024 after selling out during the quarter.
Mariner sold 10,312 CureVac shares in Q4 2024, an estimated $30.8K.
Mariner first reported a position in CureVac in Q1 2024 and held it in 3 quarters.
Mariner's CureVac position peaked at $53.1K in Q2 2024.
75 funds tracked by Wall St. Rank held CureVac as of Q4 2024.

Based on Mariner's 13F filing for Q4 2024, filed 13 Feb 2025.